Semnur Pharmaceuticals, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Semnur Pharmaceuticals, Inc. (SMNR) reported Cash and Cash Equivalents, Period Increase (Decrease) of $16.57 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-23.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2022-05-23
- Semnur Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2022-03-31 was $16.57K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month |
|---|---|
| 2022-03-31 | $16.57K 10-Q · filed 2022-05-23 |